Regulatory role of rpL3 in cell response to nucleolar stress induced by Act D in tumor cells lacking functional p53

ABSTRACT Many chemotherapeutic drugs cause nucleolar stress and p53-independent pathways mediating the nucleolar stress response are emerging. Here, we demonstrate that ribosomal stress induced by Actinomycin D (Act D) is associated to the up-regulation of ribosomal protein L3 (rpL3) and its accumulation as ribosome-free form in lung and colon cancer cell lines devoid of p53. Free rpL3 regulates p21 expression at transcriptional and post-translational levels through a molecular mechanism involving extracellular-signal-regulated kinases1/2 (ERK1/2) and mouse double minute-2 homolog (MDM2). Our data reveal that rpL3 participates to cell response acting as a critical regulator of apoptosis and cell migration. It is noteworthy that silencing of rpL3 abolishes the cytotoxic effects of Act D suggesting that the loss of rpL3 makes chemotherapy drugs ineffective while rpL3 overexpression associates to a strong increase of Act D-mediated inhibition of cell migration. Taking together our results show that the efficacy of Act D chemotherapy depends on rpL3 status revealing new specific targets involved in the molecular pathways activated by Act D in cancers lacking of p53. Hence, the development of treatments aimed at upregulating rpL3 may be beneficial for the treatment of these cancers.

[1]  A. Russo,et al.  Autoregulatory circuit of human rpL3 expression requires hnRNP H1, NPM and KHSRP , 2017, Nucleic acids research.

[2]  A. Ianaro,et al.  Human Cystathionine-β-Synthase Phosphorylation on Serine227 Modulates Hydrogen Sulfide Production in Human Urothelium , 2015, PloS one.

[3]  A. Ianaro,et al.  Correction: Human Cystathionine-β-Synthase Phosphorylation on Serine227 Modulates Hydrogen Sulfide Production in Human Urothelium , 2015, PloS one.

[4]  A. Kurisaki,et al.  Emerging roles of nucleolar and ribosomal proteins in cancer, development, and aging , 2015, Cellular and Molecular Life Sciences.

[5]  F. Ungaro,et al.  Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells , 2015, Journal of Nanobiotechnology.

[6]  Xiang Zhou,et al.  Ribosomal proteins: functions beyond the ribosome. , 2015, Journal of molecular cell biology.

[7]  Takuya Kumazawa,et al.  The nucleolar protein nucleophosmin is essential for autophagy induced by inhibiting Pol I transcription , 2015, Scientific Reports.

[8]  Jong-In Park,et al.  Sp1 regulates Raf/MEK/ERK-induced p21(CIP1) transcription in TP53-mutated cancer cells. , 2015, Cellular signalling.

[9]  S. Vishnubhatla,et al.  Prognostic factors in head and neck Ewing sarcoma family of tumors , 2015, The Laryngoscope.

[10]  E. Crescenzi,et al.  Human rpL3 plays a crucial role in cell response to nucleolar stress induced by 5-FU and L-OHP , 2014, OncoTarget.

[11]  A. Chakraborty,et al.  An overview of pre-ribosomal RNA processing in eukaryotes , 2014, Wiley interdisciplinary reviews. RNA.

[12]  M. Oren,et al.  p53 and ribosome biogenesis stress: The essentials , 2014, FEBS letters.

[13]  P. DiMario,et al.  Nucleolar stress with and without p53 , 2014, Nucleus.

[14]  R. Pearson,et al.  Targeting the nucleolus for cancer intervention. , 2014, Biochimica et biophysica acta.

[15]  D. V. Von Hoff,et al.  Targeting the nucleolus for cancer-specific activation of p53. , 2014, Drug discovery today.

[16]  D. Ho,et al.  AKT mediates actinomycin D-induced p53 expression , 2014, Oncotarget.

[17]  Giulia Russo,et al.  Discovery of a novel small molecule inhibitor targeting the frataxin/ubiquitin interaction via structure-based virtual screening and bioassays. , 2013, Journal of medicinal chemistry.

[18]  E. Crescenzi,et al.  Human rpL3 induces G₁/S arrest or apoptosis by modulating p21waf1/cip1 levels in a p53-independent manner , 2013, Cell cycle.

[19]  C. Prives,et al.  Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress , 2012, Proceedings of the National Academy of Sciences.

[20]  S. Lowe,et al.  Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. , 2012, Cancer cell.

[21]  Xiaoping Zhou,et al.  Scission of the p53-MDM2 Loop by Ribosomal Proteins. , 2012, Genes & cancer.

[22]  Varda Rotter,et al.  Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis. , 2011, Genes & cancer.

[23]  R. Hannan,et al.  Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth. , 2011, Cancer research.

[24]  F. Boisvert,et al.  The Nucleolus under Stress , 2010, Molecular Cell.

[25]  Xinbin Chen,et al.  Examination of the expanding pathways for the regulation of p21 expression and activity. , 2010, Cellular signalling.

[26]  E. Hurt,et al.  Driving ribosome assembly. , 2010, Biochimica et biophysica acta.

[27]  A. Amoresano,et al.  hnRNP H1 and intronic G runs in the splicing control of the human rpL3 gene. , 2010, Biochimica et biophysica acta.

[28]  J. Chambard,et al.  ERK and cell death: Mechanisms of ERK‐induced cell death – apoptosis, autophagy and senescence , 2010, The FEBS journal.

[29]  Yanping Zhang,et al.  Signaling to p53: ribosomal proteins find their way. , 2009, Cancer cell.

[30]  Davide Ruggero,et al.  Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency , 2008, Nature.

[31]  A. Russo,et al.  Cannabinoids reduce granuloma‐associated angiogenesis in rats by controlling transcription and expression of mast cell protease‐5 , 2008, British journal of pharmacology.

[32]  M. Osmak,et al.  Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance. , 2007, Cancer letters.

[33]  I. Grummt,et al.  Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases , 2006, Oncogene.

[34]  A. Mauro,et al.  p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells , 2005, Molecular Cancer.

[35]  S. Cook,et al.  ERK1/2 and p38 cooperate to induce a p21CIP1-dependent G1 cell cycle arrest , 2004, Oncogene.

[36]  Xinbin Chen,et al.  MDM2 Is a Negative Regulator of p21WAF1/CIP1, Independent of p53* , 2004, Journal of Biological Chemistry.

[37]  O. Ostrovsky,et al.  The Mitogen-activated Protein Kinase Cascade Promotes Myoblast Cell Survival by Stabilizing the Cyclin-dependent Kinase Inhibitor, p21WAF1 Protein* , 2003, Journal of Biological Chemistry.

[38]  Christopher J Marshall,et al.  Ras promotes p21Waf1/Cip1 protein stability via a cyclin D1‐imposed block in proteasome‐mediated degradation , 2003, The EMBO journal.

[39]  A. Borkhardt,et al.  Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines , 2002, Cancer Chemotherapy and Pharmacology.

[40]  Ying-hua Jin,et al.  Caspase 3-mediated Cleavage of p21 WAF1/CIP1 Associated with the Cyclin A-Cyclin-dependent Kinase 2 Complex Is a Prerequisite for Apoptosis in SK-HEP-1 Cells* , 2000, The Journal of Biological Chemistry.

[41]  Z. Dong,et al.  ERKs and p38 Kinase Phosphorylate p53 Protein at Serine 15 in Response to UV Radiation* , 2000, The Journal of Biological Chemistry.

[42]  M. Sone,et al.  Neural expression of hikaru genki protein during embryonic and larval development of Drosophila melanogaster , 1999, Development Genes and Evolution.